Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma

Neoplasia

Volumn 7, Issue 7, 2005, Pages 688-695

  Poetsch, Micaela ^a   Zimmermann, Anett ^a   Wolf, Eduard ^b   Kleist, Britta ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Regional Hospital   (Germany)

Author keywords

Allelic imbalance; CXPA; Epithelial and mesenchymal compartments; Pleomorphic adenoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; BENIGN TUMOR; CELL COMPARTMENTALIZATION; CHROMOSOME 17P; CHROMOSOME 6Q; CHROMOSOME 8Q; CHROMOSOME 9P; CLINICAL ARTICLE; EPITHELIUM CELL; FEMALE; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MESENCHYME CELL; MICROSATELLITE MARKER; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; SALIVARY GLAND TUMOR; TUMOR RECURRENCE;

EID: 23244460708     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.05163     Document Type: Article

References (43)

1. Su L, Morgan PR, Harrison DL, Waseem A, and Lane EB (1993). Expression of keratin mRNA in normal salivary gland epithelium and pleomorphic adenoma. J Pathol 171, 173-181.
2. Ellis GL and Auclair PL (1996). Tumors of the Salivary Glands. Atlas of Tumors Pathology, 3rd series, Fascicle 17, pp. 39-57. Armed Forced Institute of Pathology, Washington, DC.
3. Seifert G, Miehlke A, Haubrich J, and Chilla R (1984). Speicheldrüsenkrankheiten, p. 192ff. Georg Thieme Verlag, Stuttgart.
4. Mori M, Takai Y, and Sumitomo S (1992). Salivary gland tumors: a possible origin of modified myoepithelial cells in ductal basal cells. Cancer 5, 316-320.
5. Erlandson RA, Cardon-Cardo C, and Higgins PJ (1984). Histogenesis of benign pleomorphic adenoma (mixed tumor) of the major salivary glands. An ultrastructural and immunohistochemical study. Am J Surg Pathol 8, 803-820.
6. Dardick I, Nostrand AWP, van Jeans MTD, Rippstein P, and Edwards V (1983). Pleomorphic adenoma: I. Ultrastructural organization of "epithelial" regions. II. Ultrastructural organization of "stromal" regions. Hum Pathol 14, 780-809.
7. Stennert E, Guntinas-Lichius O, Klussmann JP, and Arnold G (2001). Histopathology of pleomorphic adenoma in the parotid gland: a prospective unselected series of 100 cases. Laryngoscope 111, 2195-2200.
8. Douglas JG, Einck J, Austin-Seymour M, Koh W-J, and Laramore GE (2001). Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands. Head Neck 23, 1037-1042.
9. Chen KTK (1978). Metastasizing pleomorphic adenoma of the salivary gland. Cancer 42, 2407-2411.
10. Gnepp DR (1993). Malignant mixed tumors of the salivary glands: a review. Pathol Annu 28, 279-328.
11. Mark J and Dahlenfors R (1986). Cytogenetical observations in 100 human benign pleomorphic adenomas: specificity of the chromosomal aberrations and their relationship to sites of localized oncogenes. Anticancer Res 6, 299-308.
12. El-Naggar A, Callender D, Coombes MM, Hurr K, Luna MA, and Batsakis JG (2000). Molecular genetic alterations in carcinoma expleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 27, 162-168.
13. Mantesso A, Loducca SV, Bendit I, Garicochea B, Nunes FD, and de Araujo VC (2004). Mdm2 mRNA expression in salivary gland tumour cell lines. J Oral Pathol Med 33, 96-101.
14. de Navarro RL, Martins MT, and de Araujo VC (2004). Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med 33, 435-440.
15. Felix A, Rosa JC, Fonseca I, Cidadao A, and Soares J (2004). Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Histopathology 45, 187-192.
16. Yamamoto Y, Kishimoto Y, Virmani AK, Smith A, Vuitch F, Albores-Saavedra J, and Gazdar AF (1996). Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands. Hum Pathol 27, 782-786.
17. El-Naggar AK, Hurr K, Kagan J, Gillenwater A, Callender D, Luna MA, and Batsakis JG (1997). Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol 21, 691-697.
18. Gillenwater A, Hurr K, Wolf P, Batsakis JG, Goepfert H, and El-Naggar AK (1997). Microsatellite alterations at chromosome 8q loci in pleomorphic adenoma. Otolaryngol Head Neck Surg 117, 448-452.
19. Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, and Tannapfel A (2002). Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. J Pathol 198, 326-334.
20. Weber A, Langhanki L, Schutz A, Gerstner A, Bootz F, Wittekind C, and Tannapfel A (2002). Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 441, 428-436.
21. Poetsch M, Dittberner T, and Woenckhaus C (2001). PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet Cytogenet 125, 21-26.
22. Bullerdiek J, Bartnitzke S, Weinberg M, Chilla R, Haubrich J, and Schloot W (1987). Rearrangements of chromosome region 12q13-15 in pleomorphic adenomas of the human salivary gland. Cytogenetic Cell Genet 45, 184-190.
23. Bullerdiek J, Raabe G, Bartnitzke S, Boschen C, and Schloot W (1987). Structural rearrangements of chromosome 8 involving 8q12: a primary event in pleomorphic adenomas of the parotid gland. Genetica 72, 85-92.
24. Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, and Bartnitzke S (1993). Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlations to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65, 27-31.
25. Mark HF, Hanna I, and Gnepp DR (1996). Cytogenetic analysis of salivary gland type tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 82, 187-192.
26. Johns MM III, Westra WH, Califano JA, Eisele D, Koch WM, and Sidransky D (1996). Allelotype of salivary gland tumors. Cancer Res 56, 1151-1154.
27. Suzuki H and Fujioka Y (1998). Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland. Diagn Mol Pathol 7, 224-231.
28. Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, and Konishi N (2005). Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41, 161-169.
29. El-Naggar AK, Abdul-Karim FW, Hurr K, Callender D, Luna MA, and Batsakis JG (1998). Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Genet Cytogenet 102, 19-24.
30. Queimado L, Reis A, Fonseca I, Martins C, Lovett M, Soares J, and Parreira L (1998). A refined localisation of two deleted regions in chromosome 6q associated with salivary gland carcinomas. Oncogene 16, 83-88.
31. Kishi M, Nakamura M, Nishimine M, Ishida E, Shimada K, Kirita T, and Konishi N (2003). Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas. Cancer Sci 94, 530-535.
32. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, and Lam WL (2004). Novel regions of amplification on 8q distinct from the MVC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 39, 93-98.
33. Sasiadek M, Stembalska-Kozlowska A, Smigiel R, Krecicki T, Blin N, and Mirghomizadeh F (2001). Microsatellite and chromosome instability in squamous cell laryngeal carcinoma. Int J Oncol 19, 401-405.
34. Schmutte C, Baffa R, Veronese LM, Murakumo Y, and Fishel R (1997). Human thymine-DNA glycosylase maps at chromosome 12q22-q24.1: a region of high loss of heterozygosity in gastric cancer. Cancer Res 57, 3010-3015.
35. Schneider BG, Rha SY, Chung HC, Bravo JC, Mera R, Torres JC, Plaisance KT Jr, Schlegel R, McBride CM, Reveles XT, et al. (2003). Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer. Mol Pathol 56, 141-149.
36. Yatsuoka T, Furukawa T, Abe T, Yokoyama T, Sunamura M, Kobari M, Matsuno S, and Horii A (1999). Genomic analysis of the thymine-DNA glycosylase (TOG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma. Int J Pancreatol 25, 97-102.
37. Yatsuoka T, Furukawa T, Sunamura M, Matsuno S, and Horii A (2004). TU12B1-TY, a novel gene in the region at 12q22-q23.1 frequently deleted in pancreatic cancer, shows reduced expression in pancreatic cancer cells. Oncol Rep 12, 1263-1268.
38. Ohki K, Kumamoto H, Ichinohasama R, Suzuki M, Yamaguchi T, Echigo S, Motegi K, and Ooya K (2001). Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins. Int J Oral Maxillofac Surg 30, 538-544.
39. Stallmach I, Zenklusen P, Komminoth P, Schmid S, Perren A, Roos M, Jianming Z, Heitz PU, and Pfaltz M (2002). Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 440, 77-84.
40. El-Rifal W, Rutherford S, Knuutila S, Frierson HF Jr, and Moskaluk CA (2001). Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia 3, 173-178.
41. Dardick I, Ostrynski VL, Ekem JK, Leung R, and Burford-Mason AP (1992). Immunohistochemical and ultrastructural correlates of muscle-actin expression in pleomorphic adenomas and myoepitheliomas based on comparison of formalin and methanol fixation. Virchows Arch 421, 95-104.
42. Gotte K, Riedel F, Coy JF, Spahn V, and Hormann K (2000). Salivary gland carcinosarcoma: immunohistochemical, molecular genetic and electron microscopic findings. Oral Oncol 36, 360-364.
43. Kazmierczak B, Thode B, Bartnitzke S, Bullerdiek S, and Schloot W (1992). Pleomorphic adenoma cells vary in their susceptibility to SV40 transformation depending on the initial karyotype. Genes Chromosomes Cancer 5, 35-39.